跳轉至內容
Merck

E6376

红霉素

potency: ≥850 μg per mg

同義詞:

Erythromycin A

登入 檢視組織與合約價格。

選擇尺寸

暫時無法取得訂價和供貨情況

關於此項目

經驗公式(希爾表示法):
C37H67NO13
CAS 編號:
分子量::
733.93
UNSPSC Code:
51282304
NACRES:
NA.76
PubChem Substance ID:
EC Number:
204-040-1
Beilstein/REAXYS Number:
75279
MDL number:

跳轉至

技術服務
需要援助?我們經驗豐富的科學家團隊隨時樂意為您提供支援。
讓我們為您提供幫助

產品名稱

红霉素, potency: ≥850 μg per mg

InChI key

ULGZDMOVFRHVEP-RWJQBGPGSA-N

InChI

1S/C37H67NO13/c1-14-25-37(10,45)30(41)20(4)27(39)18(2)16-35(8,44)32(51-34-28(40)24(38(11)12)15-19(3)47-34)21(5)29(22(6)33(43)49-25)50-26-17-36(9,46-13)31(42)23(7)48-26/h18-26,28-32,34,40-42,44-45H,14-17H2,1-13H3/t18-,19-,20+,21+,22-,23+,24+,25-,26+,28-,29+,30-,31+,32-,34+,35-,36-,37-/m1/s1

SMILES string

CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O

biological source

Streptomyces erythreus

form

powder

potency

≥850 μg per mg

color

white

solubility

ethanol: 50 mg/mL, clear to slightly hazy, colorless to faintly yellow

antibiotic activity spectrum

Gram-negative bacteria
Gram-positive bacteria

mode of action

protein synthesis | interferes

Quality Level

Gene Information

尋找類似的產品? 前往 產品比較指南

比較類似項目

查看完整比較

Show Differences

1 of 4

本產品
E0774PHR1039BP781
红霉素 British Pharmacopoeia (BP) Reference Standard

BP781

红霉素

mode of action

protein synthesis | interferes

mode of action

protein synthesis | interferes

mode of action

-

mode of action

-

antibiotic activity spectrum

Gram-negative bacteria, Gram-positive bacteria

antibiotic activity spectrum

Gram-negative bacteria, Gram-positive bacteria

antibiotic activity spectrum

-

antibiotic activity spectrum

-

Quality Level

200

Quality Level

200

Quality Level

300

Quality Level

-

form

powder

form

solid

form

-

form

crystalline

biological source

Streptomyces erythreus

biological source

-

biological source

-

biological source

-

potency

≥850 μg per mg

potency

-

potency

-

potency

-

Application

应用
红霉素是一种抗生素,是通过 红霉素链霉菌的某些菌株的生长而产生的。 该产品主要由红霉素A和少量红霉素B和C组成,推荐浓度为100 mg/L. 50至200mg/L的浓度范围也被证明可有效控制细菌的生长。 红霉素已被用作胃动素受体激动剂,以在体外阻断人气道中的呼吸糖结合物分泌, 并可用于质粒固化重组乳酸链球菌MG1363菌株的选择。

Biochem/physiol Actions

作用机制: 红霉素通过在转肽步骤中抑制延伸起作用,特别是通过结合细菌70S rRNA复合物的50S亚单位来抑制氨酰从A位点到P位点的易位。

抗菌谱:该产品可以抗革兰氏阴性和革兰氏阳性细菌。

Disclaimer

该产品在37℃下在溶液中可保持稳定3天。 储备溶液应储存在2-8°C。

General description

化学结构:大环内酯

Preparation Note

该产品可以2mg/mL的浓度溶于水中,0.067%的水溶液的pH值为8.0-10.5。 它也可以50mg/mL的浓度溶于乙醇中,获得澄清、无色至淡黄色的溶液。 它易溶于醇、丙酮、氯仿、乙腈和乙酸乙酯中,但会与酸形成盐。 所有溶液应保证避光。

存儲類別/等級

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)


從最近期的版本中選擇一個:

分析證明 (COA)

Lot/Batch Number

未看到正確版本?

如果您需要一個特定的版本,您可以透過批號來尋找特定憑證。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Christoph Czarnetzki et al.
JAMA surgery, 150(8), 730-737 (2015-06-18)
Patients undergoing emergency procedures under general anesthesia have impaired gastric emptying and are at high risk for aspiration of gastric contents. Erythromycin has strong gastric prokinetic properties. To evaluate the efficacy of erythromycin lactobionate in gastric emptying in patients undergoing
Leena Keurulainen et al.
Journal of medicinal chemistry, 53(21), 7664-7674 (2010-10-12)
Chlamydia pneumoniae is an intracellular bacterium that responds poorly to antibiotic treatment. Insufficient antibiotic usage leads to chronic infection, which is linked to disease processes of asthma, atherosclerosis, and Alzheimer's disease. The Chlamydia research lacks genetic tools exploited by other
Anna C Shore et al.
Antimicrobial agents and chemotherapy, 54(12), 4978-4984 (2010-10-06)
The staphylococcal cfr gene mediates resistance to phenicols, lincosamides, oxazolidinones, pleuromutilins, and streptogramin A, a phenotype that has been termed PhLOPS(A). The cfr gene has mainly been associated with coagulase-negative staphylococcal isolates from animals, and only a few cfr-positive methicillin-resistant
Elisabet I Nielsen et al.
Antimicrobial agents and chemotherapy, 51(1), 128-136 (2006-10-25)
Dosing of antibacterial agents is generally based on point estimates of the effect, even though bacteria exposed to antibiotics show complex kinetic behaviors. The use of the whole time course of the observed effects would be more advantageous. The aim
Markus Hilleringmann et al.
The EMBO journal, 28(24), 3921-3930 (2009-11-28)
Although the pili of Gram-positive bacteria are putative virulence factors, little is known about their structure. Here we describe the molecular architecture of pilus-1 of Streptococcus pneumoniae, which is a major cause of morbidity and mortality worldwide. One major (RrgB)

文章

蛋白质合成是一个复杂、多步骤过程,涉及到很多酶以及构象排列。但是,阻碍细菌蛋白质合成的大部分抗生素对该过程的干扰发生在70S细菌核糖体的30S亚基或50S亚基。

Antibiotics targeting bacterial ribosomes disrupt protein synthesis, a key process in bacterial growth inhibition.

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務